Literature DB >> 10081630

Human parvovirus B19 infection in organ transplant recipients.

S Marchand1, G Tchernia, C Hiesse, G Tertian, J Cartron, F Kriaa, S Boubenider, C Goupy, D Lecointe, B Charpentier.   

Abstract

We report a 61-yr-old kidney transplant recipient with human Parvovirus B19 (HPV B19) infection presenting as a severe pancytopenia 1 month after transplantation. Bone marrow aspiration revealed severe erythroid hypoplasia with giant and dystrophic proerythroblasts. Bone marrow cells were positive for HPV B19 DNA detected by polymerase chain reaction (PCR). Pancytopenia resolved shortly after administration of intravenous immunoglobulins. Nineteen cases of HPV B19 infection in organ transplant recipients have been so far reported in the literature. Immunocompromised patients should be considered at risk from developing symptomatic HPV B19 infections. In such patients, specific anti-HPV B19 IgM and IgG antibodies may be absent or transient and therefore their negativity cannot rule out the diagnosis of HPV B19 infestation. Bone marrow smear morphological findings may suggest the diagnosis but testing for viral DNA by PCR is mandatory. Patients may spontaneously recover. However, since specific anti-viral therapy is not currently available, intravenous immunoglobulin administration appears to be the more efficacious treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081630     DOI: 10.1034/j.1399-0012.1999.t01-1-130103.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  7 in total

Review 1.  Passive immunity in prevention and treatment of infectious diseases.

Authors:  M A Keller; E R Stiehm
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Epidemiological and clinical characteristics of human parvovirus B19 infections during 2006-2009 in Northern Greece.

Authors:  M Exindari; D Chatzidimitriou; A Melidou; G Gioula; L Ziogou; E Diza
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

Review 3.  Advances in human B19 erythrovirus biology.

Authors:  Annabelle Servant-Delmas; Jean-Jacques Lefrère; Frédéric Morinet; Sylvie Pillet
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

4.  Parvovirus b19-Induced Acute Hepatitis With Hepatosplenomegaly and Polyarthropathy.

Authors:  Ubaid Khan; Rana Uzair Ahmad; Zabeeh Ullah; Tooba Fida; Muhammad Shehryar
Journal:  Cureus       Date:  2022-01-22

5.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

6.  Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplification.

Authors:  Jean-Pierre Allain; Jocelyn Hsu; Manisha Pranmeth; Deborah Hanson; Adonis Stassinopoulos; Lucia Fischetti; Laurence Corash; Lily Lin
Journal:  J Infect Dis       Date:  2006-11-08       Impact factor: 5.226

Review 7.  Virus-Associated Nephropathies: A Narrative Review.

Authors:  Christophe Masset; Paul Le Turnier; Céline Bressollette-Bodin; Karine Renaudin; François Raffi; Jacques Dantal
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.